Forma Therapeutics Holdings, Inc. Common Stock

FMTX

Valor de mercado US$ 958 mi

Sobre: Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are Etavopivat, FT-7051, FT-8225, and others.

Funcionários: 189